Outcome variables, such as days with fever, bacteremia, antibiotics, total parenteral nutrition, time in hospital, engraftment, and transfusions
| Variable . | Home care n = 36 . | Control group 1 n = 18 . | Control group 2 n = 36 . |
|---|---|---|---|
| Days at home | 16 (0-26) | 2 (0-11)3-150 | 0 (0-3)3-150 |
| Days in hospital | 4 (0-39) | 27 (2-74)3-150 | 24 (8-73)3-150 |
| Days to discharge3-151 | 19 (10-41) | 29 (13-76)3-152 | 24 (8-73)3-153 |
| Days with fever 38.5°C | 2 (0-8) | 3 (0-24) | 2 (0-17) |
| Bacteremia | 9 (25%) | 8 (44%) | 14 (39%) |
| Days on intravenous antibiotics | 7 (0-24) | 12 (0-55) | 7 (0-35) |
| Days on intravenous analgesics | 1 (0-24) | 15 (0-71) | 6 (0-31)3-153 |
| Days on TPN | 4 (0-39) | 23 (0-55)3-150 | 10 (0-43)3-152 |
| Days to WBC count > 0.2 × 109/L | 13 (8-20) | 12 (10-22) | 12 (8-19) |
| Days to ANC > 0.5 × 109/L | 15 (9-22) | 15 (11-22) | 15 (8-22) |
| Days to platelets > 30 × 109/L | 17 (0-71) | 19 (11-180) | 17 (0-210) |
| Days with G-CSF | 6 (2-17) | 6 (0-20) | 6 (0-12) |
| No. of platelet transfusions (units) | 6 (0-19) | 10 (0-54) | 6 (0-26) |
| No. of erythrocyte transfusions (units) | 4 (0-12) | 7 (0-40)3-153 | 4 (0-34) |
| CMV reactivation (before discharge) | 5 (14%) | 7 (39%) | 7 (19%) |
| CMV reactivation (over all) | 21 (58%) | 11 (61%) | 19 (53%) |
| Variable . | Home care n = 36 . | Control group 1 n = 18 . | Control group 2 n = 36 . |
|---|---|---|---|
| Days at home | 16 (0-26) | 2 (0-11)3-150 | 0 (0-3)3-150 |
| Days in hospital | 4 (0-39) | 27 (2-74)3-150 | 24 (8-73)3-150 |
| Days to discharge3-151 | 19 (10-41) | 29 (13-76)3-152 | 24 (8-73)3-153 |
| Days with fever 38.5°C | 2 (0-8) | 3 (0-24) | 2 (0-17) |
| Bacteremia | 9 (25%) | 8 (44%) | 14 (39%) |
| Days on intravenous antibiotics | 7 (0-24) | 12 (0-55) | 7 (0-35) |
| Days on intravenous analgesics | 1 (0-24) | 15 (0-71) | 6 (0-31)3-153 |
| Days on TPN | 4 (0-39) | 23 (0-55)3-150 | 10 (0-43)3-152 |
| Days to WBC count > 0.2 × 109/L | 13 (8-20) | 12 (10-22) | 12 (8-19) |
| Days to ANC > 0.5 × 109/L | 15 (9-22) | 15 (11-22) | 15 (8-22) |
| Days to platelets > 30 × 109/L | 17 (0-71) | 19 (11-180) | 17 (0-210) |
| Days with G-CSF | 6 (2-17) | 6 (0-20) | 6 (0-12) |
| No. of platelet transfusions (units) | 6 (0-19) | 10 (0-54) | 6 (0-26) |
| No. of erythrocyte transfusions (units) | 4 (0-12) | 7 (0-40)3-153 | 4 (0-34) |
| CMV reactivation (before discharge) | 5 (14%) | 7 (39%) | 7 (19%) |
| CMV reactivation (over all) | 21 (58%) | 11 (61%) | 19 (53%) |